Abstract
The recombinant tissue plasminogen activator (t-PA) is a useful therapy for acute ischemic stroke patients, but there is a major risk factor of hemorrhagic transformation. Hyperglycemic patients are not able to admit t-PA because hyperglycemia exaggerates ischemic brain and vascular damage following transient focal cerebral ischemia and frequently induces hemorrhagic transformation of the infarct during reperfusion. However, the mechanisms underlying hemorrhagic transformation induced by hyperglycemia are still unknown. Furthermore, previous reports focused upon microscopic hemorrhage rather than macroscopic hemorrhagic transformation. In order to make these problems clear, it is necessary to establish an experimental model that induces constant macroscopic hemorrhagic transformation in the infarct area caused by middle cerebral artery occlusion and the reperfusion model on the hyperglycemic rat. This experimental study can establish the model in which macroscopic hemorrhagic transformation occurs following 1.5 h occlusion and 24 h reperfusion by using the intraluminal thread method on hyperglycemic rats. It might be useful to determine the mechanisms and understand why hyperglycemia exaggerates the causes inducing macroscopic hemorrhagic transformation in the infarct area, and this reproducible model provides a platform for evaluating treatment strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kushner M, Nencini P, Reivich M, Rango M, Jamieson D, Fazekas F, Zimmerman R, Chawluk J, Alavi A, Alves W (1990) Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol 28:129–135
McCormick MT, Muir KW, Gray CS, Walters MR (2008) Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke 39:2177–2185
NINDS RT-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Boysen G, Bluhmki E, Hoxter G, Mahagne MH (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025
NINDS RT-PA Stroke Study Group (1997) Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28:2109–2118
Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE (2002) Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 59:669–674
de Courten-Myers GM, Kleinholz M, Holm P, DeVoe G, Schmitt G, Wagner KR, Myers RE (1992) Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med 21:120–126
Bemeur C, Ste-Marie L, Montgomery J (2007) Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem Int 50:890–904
Dietrich WD, Alonso O, Busto R (1993) Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24:111–116
Ennis SR, Keep RF (2007) Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 27:1573–1582
Kamada H, Yu F, Nito C, Chan PH (2007) Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 38:1044–1049
Kawai N, Stummer W, Ennis SR, Betz AL, Keep RF (1999) Blood-brain barrier glutamine transport during normoglycemic and hyperglycemic focal cerebral ischemia. J Cereb Blood Flow Metab 19:79–86
Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G (2007) Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke 38:1362–1367
Tsubokawa T, Jadhav V, Solaroglu I, Shiokawa Y, Konishi Y, Zhang JH (2007) Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38:1057–1062
Yin D, Zhou C, Kusaka I, Calvert JW, Parent AD, Nanda A, Zhang JH (2003) Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab 23:855–864
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag/Wien
About this chapter
Cite this chapter
Tsubokawa, T., Joshita, H., Shiokawa, Y., Miyazaki, H. (2011). Hyperglycemia and Hemorrhagic Transformation of Cerebral Infarction: A Macroscopic Hemorrhagic Transformation Rat Model. In: Zhang, J., Colohan, A. (eds) Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum, vol 111. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0693-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0693-8_8
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0692-1
Online ISBN: 978-3-7091-0693-8
eBook Packages: MedicineMedicine (R0)